Search

everythinglearnresearchcommunity

for

Search:↓

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Blocking a specific protein signal can make hair grow on mouse nipples.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Minoxidil and ATRA together boost hair growth more effectively than minoxidil alone.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Brazilian keratin treatments can straighten hair but may contain harmful formaldehyde.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Stem cell therapy may help treat tough hair loss cases.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Researchers isolated a new type of stem cell from mouse skin that can renew itself and turn into multiple cell types.

Trichoscopy is a useful tool for diagnosing hair disorders without pulling out hair.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

Early diagnosis and treatment of TPP can prevent complications.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.